Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2018 | 12-2017 | |
| Sales | 46,881 | 44,876 | 48,354 | 2,000 | 0 |
| Cost of Goods | 36,090 | 35,306 | 38,743 | 254 | N/A |
| Gross Profit | 10,791 | 9,570 | 9,611 | 1,746 | N/A |
| Operating Expenses | 21,867 | 10,514 | 11,610 | 2,181 | 1,680 |
| Operating Income | -10,986 | -638 | -1,256 | -181 | -1,680 |
| Interest Expense | 3,886 | 1,483 | 1,672 | 0 | 0 |
| Other Income | 818 | 0 | -657 | -251 | -111 |
| Pre-tax Income | -14,054 | -2,121 | -3,585 | -432 | -1,791 |
| Income Tax | 7,176 | 442 | 234 | -52 | -36 |
| Net Income Continuous | -21,230 | -2,563 | -3,819 | -380 | -1,755 |
| Net Income | $-21,230 | $-2,563 | $-3,819 | $-380 | $-1,755 |
| EPS Basic Total Ops | -4.12 | -34.87 | -36.39 | -10.00 | -40.00 |
| EPS Basic Continuous Ops | -3.99 | -16.26 | -24.23 | -6.99 | -37.20 |
| EPS Diluted Total Ops | -4.12 | -34.87 | -36.39 | -10.00 | -40.00 |
| EPS Diluted Continuous Ops | -3.99 | -16.26 | -24.23 | -6.99 | -37.20 |
| EBITDA(a) | $-8,422 | $-328 | $-795 | $-24 | $-1,475 |